Abstract: FR-PO114
Identifying Key Challenges and Opportunities in the Care of AKI Survivors Not on Dialysis: AKINow Workgroup
Session Information
- AKI: Epidemiology, Risk Factors, Prevention
November 04, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
Abstract Time: 10:00 AM - 12:00 PM
Category: Acute Kidney Injury
- 102 AKI: Clinical‚ Outcomes‚ and Trials
Authors
- Abdel-Rahman, Emaad M., UVA Health, Charlottesville, Virginia, United States
- Silver, Samuel A., Queens University, Kingston, Ontario, Canada
- Barreto, Erin F., Mayo Clinic Minnesota, Rochester, Minnesota, United States
- Cerda, Jorge, Albany Medical College, Albany, New York, United States
- Gewin, Leslie S., Washington University in St Louis, St Louis, Missouri, United States
- Neyra, Javier A., University of Kentucky, Lexington, Kentucky, United States
- Ng, Jia Hwei, Northwell Health, Glen Cove, New York, United States
- Vijayan, Anitha, Washington University in St Louis, St Louis, Missouri, United States
Background
ASN recently established the AKINow initiative aiming to promote excellence in the prevention and treatment of AKI. One of the core policy, practice and research objectives of this workgroup is to identify gaps in the care of AKI survivors post hospitalization and develop quality evidence and benchmark existing strategies to care for these patients including insights from other stakeholders
Methods
We held a focus group with key stakeholders that included nephrologists, primary care providers, advanced practice providers (APP), intensivists, pediatric providers, community providers, patients and allied health personnel. We sought perspectives on optimal plans for hospital discharge of AKI survivors, challenges and opportunities in their care, communication strategies across diverse stakeholders, patient and care partner education and activation, and preferred interventions
Results
While 54% of the participants (n=57) identified integrated care delivery among providers to be the biggest barrier for care of AKI survivors, 23% thought that education and awareness among patients are the main challenge. 79% of the participants recommended RAAS blockers resumption should be after serum creatinine returns to baseline/ new baseline. They further suggested that currently 95% of the care of AKI survivors is shouldered by nephrologists. This care is shared by Internists (51%), pharmacists (51%), RN (43%), APP (43%) and by other allied health personnel (8-22%). AKI patients’ survivor testimonial about their experiences highlighted some of the gaps encountered in their care. Four breakout sessions (12-15/session) suggested specific recommendations to inform who is currently followed after AKI and by whom, different options for care delivery, and potential interventions/practices that may improve clinical and patient-centered outcomes
Conclusion
The stakeholder relationships formed, including those with patients, industry, and academia, will facilitate a collaborative research and practice agenda to advise the best and efficient practices after AKI. This represents an opportunity for the “recovery after AKI” workgroup of AKINow to provide leadership by raising awareness and promoting strategies focused on equitable and effective post-AKI care throughout the ASN and wider nephrology community